Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Optimizing Patient-focused Medicine
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases.
View Our Pipeline
Accelerating the Development of Precision Science
Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Explore Our ScienceEmail Alerts
Sign up today and receive company updates to your inbox.